Self-Reported Neuropsychiatric Post–COVID-19 Condition and CSF Markers of Neuroinflammation
Shelli F. Farhadian, MD, PhD1,2,3,4; Hailey D. Reisert, BS1; Lindsay McAlpine, MD3; et al, MA3,4 JAMA Netw Open. 2023;6(11):e2342741. doi:10.1001/jamanetworkopen.2023.42741 Introduction Long COVID, also known as post–COVID-19 condition (PCC), refers to a range of symptoms that may persist for weeks to months after acute COVID-19. A subset of people with PCC report neuropsychiatric symptoms (neuro-PCC); however, the mechanisms behind this phenomenon are not yet understood.1 Cerebrospinal […]